Literature DB >> 31872533

Anaplastic variant of diffuse large B-cell lymphoma: Reappraisal as a nodal disease with sinusoidal involvement.

Nirmeen A Megahed1,2, Kei Kohno1, Ayako Sakakibara1, Ahmed E Eladl1,2, Ahmed A Elsayed1,2, Chun-Chieh Wu1,3, Yuka Suzuki1, Taishi Takahara4, Seiichi Kato5, Shigeo Nakamura1, Akira Satou4, Naoko Asano6.   

Abstract

Anaplastic variant (av) of diffuse large B-cell lymphoma (DLBCL) is morphologically defined in the 2017 World Health Organization classification, but still an enigmatic disease in its clinicopathologic distinctiveness, posing the differential diagnostic problem from gray zone lymphoma (GZL) and classic Hodgkin lymphoma (cHL). Thirty-one cases previously diagnosed as avDLBCL were reassessed. Of these, 27 (87%) and 4 (13%) were node-based and extranodal diseases, respectively. They were further reclassified into nodal avDLBCL (n = 18), nodal CD30+ DLBCL with T-cell/histiocyte-rich large B-cell lymphoma-like features (CD30+ DLBCL-THRLBCL) (n = 6), GZL with features intermediate between DLBCL and cHL (n = 3) and CD30+ extranodal DLBCL, NOS (n = 4). The nodal avDLBCL cases had a sheet-like proliferation of large cells and/or Hodgkin/Reed-Sternberg (HRS)-like cells in 12 (67%) notably with a sinusoidal pattern in 16 (89%). They showed an expression of CD20 and/or CD79a in all and CD30 in 15 of 18. All of them were negative for PD-L1 on tumor cells, although HRS-like cells showed negativity or partial loss of other B-cell markers to varying degrees. The present study highlighted the distinctiveness of the nodal avDLBCL with sinusoidal pattern, but without neoplastic PD-L1 expression, which provide refined diagnostic criteria for a more precise pathologic and clinical characterization of this disease.
© 2019 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  PD-L1; anaplastic variant; classic Hodgkin lymphoma; diffuse large B-cell lymphoma; gray zone lymphoma

Mesh:

Substances:

Year:  2019        PMID: 31872533     DOI: 10.1111/pin.12871

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

Review 1.  Hodgkin Lymphoma: Biology and Differential Diagnostic Problem.

Authors:  Taishi Takahara; Akira Satou; Toyonori Tsuzuki; Shigeo Nakamura
Journal:  Diagnostics (Basel)       Date:  2022-06-20

2.  Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report.

Authors:  Nobumasa Hojo; Makoto Nagasaki; Yasuha Mihara
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

3.  Primary splenic anaplastic variant of diffuse large B-cell lymphoma: a case report.

Authors:  Sawsan Ismail; Filip Ali; Hussein Ajamieh; Samir Kanaan; Rana Issa; Ali Daoud; Zuheir Alshehabi
Journal:  J Med Case Rep       Date:  2021-05-06

4.  CD30-Positive Anaplastic Variant of Diffuse Large B-cell Lymphoma: Frequency and Association With Clinicopathological Parameters.

Authors:  Atif A Hashmi; Rimsha Haider; Gul Nargus; Omer Ahmed; Syed Rafay Yaqeen; Ishaq Azeem Asghar; Anoshia Afzal; Muhammad Irfan; Muhammad M Edhi; Javaria Ali
Journal:  Cureus       Date:  2021-02-07

Review 5.  Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief review.

Authors:  Ayako Sakakibara; Kei Kohno; Eri Ishikawa; Yuka Suzuki; Yuta Tsuyuki; Satoko Shimada; Kazuyuki Shimada; Akira Satou; Taishi Takahara; Akiko Ohashi; Emiko Takahashi; Seiichi Kato; Shigeo Nakamura; Naoko Asano
Journal:  J Clin Exp Hematop       Date:  2021-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.